Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Operating Expenses | 9,224 | 8,309 | 11,784 | 6,831 | 3,614 |
| Operating Income | -9,224 | -8,309 | -11,784 | -6,831 | -3,614 |
| Interest Expense | 382 | 151 | 0 | 0 | 12 |
| Other Income | 1,121 | 258 | 51 | 6 | -26,627 |
| Pre-tax Income | -8,485 | -8,202 | -11,732 | -6,826 | -30,253 |
| Net Income Continuous | -8,485 | -8,202 | -11,732 | -6,826 | -30,253 |
| Net Income | $-8,485 | $-8,202 | $-11,732 | $-6,826 | $-30,253 |
| EPS Basic Total Ops | -0.25 | -0.32 | -0.47 | -0.29 | -2.83 |
| EPS Basic Continuous Ops | -0.25 | -0.32 | -0.47 | -0.29 | -2.22 |
| EPS Diluted Total Ops | -0.25 | -0.32 | -0.47 | -0.29 | -2.83 |
| EPS Diluted Continuous Ops | -0.25 | -0.32 | -0.47 | -0.29 | -2.22 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -0.32 | -0.47 | -0.29 | -1.37 |
| EBITDA(a) | $-8,842 | $-8,158 | $-11,784 | $-6,831 | $-3,614 |